Current early diagnostic biomarkers of prostate cancer

por Qu, Min, Ren, Shan-Cheng, Sun, Ying-Hao
Publicado 2014

Prostate cancer risk prediction models in Eastern Asian populations: current status, racial difference, and future directions

por He, Bi-Ming, Chen, Rui, Sun, Tian-Qi, Yang, Yue, Zhang, Chun-Lei, Ren, Shan-Cheng, Gao, Xu, Sun, Ying-Hao
Publicado 2019

Initial experience on extraperitoneal single-port robotic-assisted radical prostatectomy

por Chang, Yi-Fan, Gu, Di, Mei, Ni, Xu, Wei-Dong, Lu, Xiao-Jun, Xiao, Yu-Tian, Xu, Chuan-Liang, Sun, Ying-Hao, Ren, Shan-Cheng
Publicado 2021

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy

por Wang, Fu-Bo, Chen, Rui, Ren, Shan-Cheng, Shi, Xiao-Lei, Zhu, Ya-Sheng, Zhang, Wei, Jing, Tai-Le, Zhang, Chao, Gao, Xu, Hou, Jian-Guo, Xu, Chuan-Liang, Sun, Ying-Hao
Publicado 2017

Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion

por Sun, Yi, Wei, Min, Ren, Shan-Cheng, Chen, Rui, Xu, Wei-Dong, Wang, Fu-Bo, Lu, Ji, Shen, Jian, Yu, Yong-Wei, Hou, Jian-Guo, Xu, Chuan-Liang, Huang, Jiao-Ti, Sun, Ying-Hao
Publicado 2014

Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography

por Yu, Guo-Peng, Na, Rong, Ye, Ding-Wei, Qi, Jun, Liu, Fang, Chen, Hai-Tao, Wu, Yi-Shuo, Zhang, Gui-Ming, Sun, Jie-Lin, Zhu, Yao, Huang, Li-Qun, Ren, Shan-Cheng, Jiang, De-Ke, Zheng, S L, Jiang, Hao-Wen, Sun, Ying-Hao, Ding, Qiang, Xu, Jianfeng
Publicado 2016

A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized...

por He, Bi-Ming, Xue, Wei, Yan, Wei-Gang, Yin, Lei, Dong, Bai-Jun, Zhou, Zhi-En, Lin, Heng-Zhi, Zhou, Yi, Wang, Yan-Qing, Shi, Zhen-Kai, Zhou, Hai, Wang, Shuai-Dong, Ren, Shan-Cheng, Gao, Xu, Wang, Lin-hui, Xu, Chuan-Liang, Wang, Hai-Feng
Publicado 2021

CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer

por Qin, Xiao-Ping, Lu, Qi-Ji, Yang, Cheng-Huizi, Wang, Jue, Chen, Jian-Fan, Liu, Kan, Chen, Xin, Zhou, Jing, Pan, Yu-Hang, Li, Yong-Hong, Ren, Shan-Cheng, Liu, Jiu-Min, Liu, Wei-Peng, Qian, Hui-Jun, Yi, Xian-Lin, Lai, Cai-Yong, Qu, Li-Jun, Gao, Xin, Xu, Yu-Sheng, Chen, Zheng, Zhuo, Yu-Min
Publicado 2022

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(−1)

por Chen, Rui, Zhou, Li-Qun, Cai, Xiao-Bing, Xie, Li-Ping, Huang, Yi-Ran, He, Da-Lin, Gao, Xu, Xu, Chuan-Liang, Ding, Qiang, Wei, Qiang, Yin, Chang-Jun, Ren, Shan-Cheng, Wang, Fu-Bo, Tian, Ye, Sun, Zhong-Quan, Fu, Qiang, Ma, Lu-Lin, Zheng, Jun-Hua, Ye, Zhang-Qun, Ye, Ding-Wei, Xu, Dan-Feng, Hou, Jian-Quan, Xu, Ke-Xin, Yuan, Jian-Lin, Gao, Xin, Liu, Chun-Xiao, Pan, Tie-Jun, Sun, Ying-Hao
Publicado 2015